Atommap Corp-preview

Atommap

Atommap Corp

Private

New York City, New YorkHealthcare & Life Scienceshttps://www.atommap.com/

Last Round

Series A

Apr 27, 2026

Total Funding Raised

$54.08M

Company Overview

Atommap Corp is a biotechnology company that invents therapeutic molecules using quantum physics, AI, and computation-driven design at atomic precision.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms, Cloud Infrastructure

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Revenue Share, Subscription SaaS

AI Layer

Application

Keywords

computational drug discoveryAI drug discoverycomputational molecular designdrug discovery platformin silico drug discoverymolecular dynamicsintractable drug targetsphysics-based simulationsgenerative designgenerative chemistrycomputational chemistryhigh-performance computingHPCmolecular discovery as a serviceMDaaScomputation as a serviceCaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Atommap Corp Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Atommap Corp Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Apr 27, 2026
Early Stage VC	Mar 20, 2026
Seed	Nov 16, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Huafeng Xu

Founder And CEO

Founding Team

Yujie Wu

Chief Technology Officer

Executive Team

Atommap Corp Investors

Notable investors and investment history

Investor	Rounds
Chemistry VC	Series A
Alexandria Venture Investments	Series A
New York Ventures	Series A
Sutter Hill Ventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 27, 2026
$47M Series A round completed.

View all signals

Atommap Corp Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Atommap Corp Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Atommap Corp's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York

Employee Range19

Year Founded2023

Last FundingApr 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.